Funder: National Institutes of Health

Due Dates: June 20, 2025 (New) | July 18, 2025 (Renewal/Resubmission/Revision) | October 20, 2025 (New) | November 19, 2025 (Renewal/Resubmission/Revision) | February 19, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | June 18, 2026 (New) | July 20, 2026 (Renewal/Resubmission/Revision) | October 19, 2026 (New) | November 19, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: No set budget limit; UG3 phase up to 1 year, UH3 phase up to 4 years (up to 6 years with strong justification); budgets must reflect actual project needs.

Summary: Supports multi-site clinical trials, biomarker validation, and ancillary studies for stroke treatment, recovery, and prevention, conducted within the NIH StrokeNet infrastructure.

Key Information: All applications must use NIH StrokeNet infrastructure; prior NINDS approval required before submission; foreign organizations may not apply, but foreign components are allowed.